Daniel R. Deaver
49Patents
14h-index
16Co-inventors
78Inventor score
Filing activity: Mar 3, 1997 → Mar 27, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5985320A | Materials and methods for enhancing cellular internalization | Emerging Cross-Sectional Technologies | 229 | Expired |
| US6387390B1 | Compositions and methods for enhancing receptor-mediated cellular internalization | Emerging Cross-Sectional Technologies | 62 | Expired |
| US8822488B2 | Compositions of buprenorphine and μ antagonists | Human Necessities | 57 | Active |
| USRE42012E1 | Compositions and methods for enhancing receptor-mediated cellular internalization | General | 55 | Active |
| USRE42072E1 | Compositions and methods for enhancing receptor-mediated cellular internalization | General | 52 | Active |
| US9211293B2 | Opioid agonist antagonist combinations | Human Necessities | 41 | Active |
| US8778960B2 | Methods for treating antipsychotic-induced weight gain | Chemistry; Metallurgy | 25 | Active |
| US9034867B2 | Pharmaceutical compositions comprising sorbitan esters | Human Necessities | 25 | Active |
| US9351976B2 | Pharmaceutical compositions comprising sorbitan esters | Human Necessities | 22 | Active |
| US6908623B2 | Compositions and methods for enhancing receptor-mediated cellular internalization | Emerging Cross-Sectional Technologies | 19 | Expired |
| US8354534B2 | Selective opioid compounds | Chemistry; Metallurgy | 17 | Active |
| US6652873B2 | Compositions and methods for enhancing receptor-mediated cellular internalization | Emerging Cross-Sectional Technologies | 17 | Expired |
| US9193685B2 | Pharmaceutical compositions having improved storage stability | Chemistry; Metallurgy | 15 | Active |
| US9416137B2 | Morphan and morphinan analogues, and methods of use | Chemistry; Metallurgy | 15 | Active |
| US9682936B2 | Morphan and morphinan analogues, and methods of use | Chemistry; Metallurgy | 14 | Active |
| US9656961B2 | Methods for treating depressive symptoms | Chemistry; Metallurgy | 13 | Active |
| US9126977B2 | Methods for treating antipsychotic-induced weight gain | Chemistry; Metallurgy | 12 | Active |
| US9517235B2 | Methods for treating antipsychotic-induced weight gain | Chemistry; Metallurgy | 12 | Active |
| US9943514B2 | Methods for treating antipsychotic-induced weight gain | Chemistry; Metallurgy | 9 | Active |
| US10300054B2 | Methods for treating antipsychotic-induced weight gain | Chemistry; Metallurgy | 9 | Active |
| US9861699B2 | Pharmaceutical compositions having improved storage stability | Chemistry; Metallurgy | 8 | Active |
| US10287250B2 | Morphan and morphinan analogues, and methods of use | Chemistry; Metallurgy | 8 | Active |
| US10736890B2 | Methods for treating depressive symptoms | Chemistry; Metallurgy | 8 | Active |
| US10716785B2 | Methods for treating antipsychotic-induced weight gain | Chemistry; Metallurgy | 8 | Active |
| US10752592B2 | Morphan and morphinan analogues, and methods of use | Chemistry; Metallurgy | 8 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.